Name: What is MRD, or Minimal Residual Disease?
Uploaded: 2018-01-25T13:40:43-0800
Duration: 3 min 43 s
Description: In this week’s video, Dr. Brian G.M. Durie defines minimal residual disease (MRD) and explains how MRD-testing can be used for ongoing monitoring. BOTTOM LINE: As it may one day be a guide for assessing treatment outcomes, myeloma patients should familiarize themselves with MRD-testing.

In this week’s video, Dr. Brian G.M. Durie defines minimal residual disease (MRD) and explains how MRD-testing can be used for ongoing monitoring.

BOTTOM LINE:

As it may one day be a guide for assessing treatment outcomes, myeloma patients should familiarize themselves with MRD-testing.

If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].

To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.